Medical Discovery News

New Hope for those with Macular Degeneration

Medical Discovery News Season 21 Episode 1007

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 1:59

1007  New Hope for those with Macular Degeneration

Welcome to Medical Discovery News.  I’m Dr. David Niesel.

And I’m Dr. Norbert Herzog. 

I played pin the tail on the donkey as a kid and even though it was a game, I did not like trying to do something blindfolded. So I can’t imagine not seeing except now that I’m getting older, a risk I face is macular degeneration. 

No kidding, Norbert…we both do. But there’s a new prosthetic being tested that restored sight to people with AMD, age-related macular degeneration. AMD affects people over age fifty and is a leading cause of vision loss in older adults. 

The macula is a part of the retina at the back of the eye responsible for sharp, central vision needed for activities like reading, driving, and recognizing faces. 

There is dry AMD and wet AMD. Dry being the most common, when the light sensitive receptors in the macula are destroyed causing gradual vision loss. 

The less common wet AMD is more severe. Fluid or blood leaks beneath the retina leading to vision loss. There is no cure except now biomedical research has produced a tiny wireless microchip implanted in the retina. 

Of the study’s thirty-two patients with advanced AMD, twenty-seven could read again within a year. The chip stands in for damaged retinal photoreceptors and works with the camera on a pair of special eyeglasses. 

Infrared light going into the camera is wirelessly projected on the chip which then sends electric signals that the brain interprets. 

For now the images are black and white with low resolution, but as the tech improves, it will change people’s lives.    

We are Drs. David Niesel and Norbert Herzog, at UTMB and Quinnipiac University, where biomedical discoveries shape the future of medicine.   For much more and our disclaimer go to medicaldiscoverynews.com or subscribe to our podcast.